Pear Therapeutics: Funding, Investors & Team (Oct 2026)
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
Pear Therapeutics has raised $145M across 2 funding rounds on record, the most recent a Post-IPO Equity of $125M announced in Dec 2021.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pear Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2021.
Pear Therapeutics Funding Rounds
Pear Therapeutics raised $20.0M in a Series D announced in Mar 2021.
9 months later, a Post-IPO Equity of $125M was announced in Dec 2021.
Pear Therapeutics Founders and Leadership Team
Contact details for the Pear Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Pear Therapeutics Funding Compared to Other Biotechnology Startups
Pear Therapeutics' latest round of $125M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pear Therapeutics in Biotechnology and Boston
Companies Similar to Pear Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Pear Therapeutics Funding FAQs
What does Pear Therapeutics do?
Pear Therapeutics is a provider of a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals. The company's platform combines novel digital interventions with drugs to enhance efficacy well beyond anything that is commercially available or in clinical development, enabling clients to get better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective services for payors.
How much funding has Pear Therapeutics raised?
Pear Therapeutics has raised $145M across 2 rounds on record. The most recent is a Post-IPO Equity of $125M announced in Dec 2021.
When did Pear Therapeutics last raise funding?
Pear Therapeutics' most recent funding round on record is a Post-IPO Equity of $125M, announced in Dec 2021.
Who is the CEO of Pear Therapeutics?
Corey McCann is listed as CEO at Pear Therapeutics.
Where is Pear Therapeutics headquartered?
Pear Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Pear Therapeutics have?
Pear Therapeutics is in the 251-500 employee band.
How does Pear Therapeutics' funding compare to other Biotechnology startups?
Pear Therapeutics' latest round of $125M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Pear Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pear Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.